Carson Wealth (CWM LLC)’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $4K | Buy |
1,707
+497
| +41% | +$1.17K | ﹤0.01% | 4690 |
|
2025
Q1 | $3K | Buy |
1,210
+97
| +9% | +$240 | ﹤0.01% | 4643 |
|
2024
Q4 | $6K | Sell |
1,113
-2,402
| -68% | -$12.9K | ﹤0.01% | 4129 |
|
2024
Q3 | $29K | Sell |
3,515
-38
| -1% | -$314 | ﹤0.01% | 3118 |
|
2024
Q2 | $25K | Sell |
3,553
-892
| -20% | -$6.28K | ﹤0.01% | 2971 |
|
2024
Q1 | $39K | Sell |
4,445
-236,817
| -98% | -$2.08M | ﹤0.01% | 2461 |
|
2023
Q4 | $1.58M | Sell |
241,262
-8,899
| -4% | -$58.3K | 0.01% | 634 |
|
2023
Q3 | $2.5M | Sell |
250,161
-6,839
| -3% | -$68.4K | 0.02% | 498 |
|
2023
Q2 | $3.2M | Buy |
257,000
+57,224
| +29% | +$711K | 0.02% | 433 |
|
2023
Q1 | $2.8M | Buy |
199,776
+53,247
| +36% | +$746K | 0.02% | 429 |
|
2022
Q4 | $2.1M | Sell |
146,529
-29,749
| -17% | -$426K | 0.02% | 437 |
|
2022
Q3 | $4.5M | Sell |
176,278
-7,518
| -4% | -$192K | 0.04% | 298 |
|
2022
Q2 | $5.22M | Sell |
183,796
-27,864
| -13% | -$792K | 0.04% | 287 |
|
2022
Q1 | $7.47M | Sell |
211,660
-28,062
| -12% | -$990K | 0.05% | 247 |
|
2021
Q4 | $10M | Buy |
+239,722
| New | +$10M | 0.07% | 209 |
|